Skip to main content
Jennifer Choi, MD, Dermatology, Chicago, IL, Northwestern Memorial Hospital

JenniferNamChoiMD

Dermatology Chicago, IL

Associate Professor, Dermatology; Chief, Division of Oncodermatology; Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center

Dr. Choi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Choi's full profile

Already have an account?

Summary

  • Dr. Jennifer Choi is a dermatologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Northwestern Memorial Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago. She received her medical degree from Yale School of Medicine and has been in practice 14 years. She is experienced in chemotherapy, melanoma, and drug eruptions.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Dermatology, 2004 - 2007
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 2003 - 2004
  • Yale School of Medicine
    Yale School of MedicineClass of 2003

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2015 - 2026
  • CT State Medical License
    CT State Medical License 2007 - 2016
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow (FAAD) American Academy of Dermatology

Publications & Presentations

PubMed

Lectures

  • Caring for the Cancer Patient: Challenging Cases From Inpatient and Outpatient Oncodermatology Consultative Services 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Press Mentions

  • Current Evidence for Safety and Efficacy of Anti-PD-1 Agents in the Treatment of Cutaneous Squamous Cell Carcinoma: A Systematic Review
    Current Evidence for Safety and Efficacy of Anti-PD-1 Agents in the Treatment of Cutaneous Squamous Cell Carcinoma: A Systematic ReviewSeptember 26th, 2019
  • Northwestern Dermatology Faculty
    Northwestern Dermatology FacultyDecember 24th, 2020
  • No OS Benefit for Adjuvant Treatment of Stage III Melanoma
    No OS Benefit for Adjuvant Treatment of Stage III MelanomaJune 17th, 2023

Professional Memberships

Hospital Affiliations

Industry Relationships

  • Advisory Board Member, Biotest AG